Pivotal Implant Study Drug Refractory Epilepsy

February 9, 2018

Challenge

ThreeWire was called on to assist the sponsor with completing enrollment ahead of multiple competitors with similar study designs and timelines.

Solution

ThreeWire implemented media outreach, online recruitment and site kits. Respondents were prescreened by our Patient Interaction Center® and qualified candidates were referred to participating sites.

Results

1,412 referrals were generated to sites. Issues with reimbursement for sitebased diagnostic testing caused the sponsors to stop media outreach and focus on site-based and online recruitment. Media outreach produced 422 referrals and 5 enrollments. Online and site-based recruitment generated 921 and 69 referrals respectively. Although enrollment numbers were not tracked, the campaign continued through the end of study enrollment, which finished more than 6 months ahead of the nearest competitor

 

Previous Flipbook
Patient Enrollment Marketing for Phase IIB OAB Drug-  North America, South America, Western Europe, Eastern Europe, Asia, Australia, Africa
Patient Enrollment Marketing for Phase IIB OAB Drug- North America, South America, Western Europe, Eastern Europe, Asia, Australia, Africa

Retain 700 subjects who completed the first part of the study into a 52-week extension study across six con...

Next Flipbook
Patient Enrollment Marketing for Medical Device Sleep Study
Patient Enrollment Marketing for Medical Device Sleep Study

The protocol design for this pivotal study required extensive pre-enrollment sleep studies, followed by mul...